Literature DB >> 28804789

Obesity and Breast Cancer: Do Age, Race and Subtype Matter?

Kimberly M Arnold1,2, Nicole J Flynn1,3, Jennifer Sims-Mourtada1,2,3.   

Abstract

Obesity rates within the United States are on the rise. Obesity is a known risk factor for various diseases, including cancer. Numerous studies have linked obesity to the incidence and treatment outcomes of breast cancer. However, the risk of obesity may vary between breast cancer subtypes and different racial or age groups. In this article, we review the literature regarding the impact of obesity on incidence and response for different subtypes of breast cancer within different population groups.

Entities:  

Year:  2016        PMID： 28804789      PMCID： PMC5553910     

Source DB:  PubMed          Journal:  BAOJ Cancer Res Ther


  46 in total

1.  Body mass index and weight change in relation to triple-negative breast cancer survival.

Authors:  Ping-Ping Bao; Hui Cai; Peng Peng; Kai Gu; Yinghao Su; Xiao-Ou Shu; Ying Zheng
Journal:  Cancer Causes Control       Date:  2015-11-30       Impact factor: 2.506

2.  Effect of obesity on prognosis after early-stage breast cancer.

Authors:  Marianne Ewertz; Maj-Britt Jensen; Katrín Á Gunnarsdóttir; Inger Højris; Erik H Jakobsen; Dorte Nielsen; Lars E Stenbygaard; Ulla B Tange; Søren Cold
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

3.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

4.  Body mass and mortality after breast cancer diagnosis.

Authors:  Maura K Whiteman; Susan D Hillis; Kathryn M Curtis; Jill A McDonald; Phyllis A Wingo; Polly A Marchbanks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-08       Impact factor: 4.254

5.  Obesity and weight change in relation to breast cancer survival.

Authors:  Xiaoli Chen; Wei Lu; Wei Zheng; Kai Gu; Zhi Chen; Ying Zheng; Xiao Ou Shu
Journal:  Breast Cancer Res Treat       Date:  2010-01-08       Impact factor: 4.872

6.  The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.

Authors:  Evandro de Azambuja; Worta McCaskill-Stevens; Prudence Francis; Emmanuel Quinaux; John P A Crown; Malou Vicente; Rosa Giuliani; Bo Nordenskjöld; Jorge Gutiérez; Michael Andersson; Mireia Margeli Vila; Raimund Jakesz; Jan Demol; Joanna Dewar; Armando Santoro; Ana Lluch; Steven Olsen; Richard D Gelber; Angelo Di Leo; Martine Piccart-Gebhart
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

7.  Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience.

Authors:  G Berclaz; S Li; K N Price; A S Coates; M Castiglione-Gertsch; C-M Rudenstam; S B Holmberg; J Lindtner; D Erien; J Collins; R Snyder; B Thürlimann; M F Fey; C Mendiola; I Dudley Werner; E Simoncini; D Crivellari; R D Gelber; A Goldhirsch
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

8.  Is obesity an independent prognosis factor in woman breast cancer?

Authors:  Bilal Majed; Thierry Moreau; Kamel Senouci; Rémi J Salmon; Alain Fourquet; Bernard Asselain
Journal:  Breast Cancer Res Treat       Date:  2007-10-16       Impact factor: 4.872

9.  The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.

Authors:  Peter Widschwendter; Thomas Wp Friedl; Lukas Schwentner; Nikolaus DeGregorio; Bernadette Jaeger; Amelie Schramm; Inga Bekes; Miriam Deniz; Krisztian Lato; Tobias Weissenbacher; Bernd Kost; Ulrich Andergassen; Julia Jueckstock; Julia Neugebauer; Elisabeth Trapp; Peter A Fasching; Matthias W Beckmann; Andreas Schneeweiss; Ines Schrader; Brigitte Rack; Wolfgang Janni; Christoph Scholz
Journal:  Breast Cancer Res       Date:  2015-09-18       Impact factor: 6.466

10.  Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis.

Authors:  Bella Pajares; Marina Pollán; Miguel Martín; John R Mackey; Ana Lluch; Joaquín Gavila; Charles Vogel; Manuel Ruiz-Borrego; Lourdes Calvo; Tadeusz Pienkowski; Álvaro Rodríguez-Lescure; Miguel Angel Seguí; Olivier Tredan; Antonio Antón; Manuel Ramos; María del Carmen Cámara; César Rodríguez-Martín; Eva Carrasco; Emilio Alba
Journal:  Breast Cancer Res       Date:  2013-11-06       Impact factor: 6.466
View more
  1 in total

1.  Weight Gain after Hormone Receptor-Positive Breast Cancer.

Authors:  Archita Goyal; Gabrielle E Milner; Ashley Cimino-Mathews; Kala Visvanathan; Antonio C Wolff; Dipali Sharma; Jennifer Y Sheng
Journal:  Curr Oncol       Date:  2022-06-06       Impact factor: 3.109
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.